JSPR
Jasper Therapeutics Inc
NASDAQ: JSPR · HEALTHCARE · BIOTECHNOLOGY
$0.94
+5.13% today
Updated 2026-04-30
Market cap
$26.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.95
Dividend yield
—
52W range
$1 – $7
Volume
0.4M
Jasper Therapeutics Inc (JSPR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.97M | $-18.27M | $-33.68M | $-45.86M | $-52.07M | $-62.60M | $-77.16M |
| Capital expenditures | $2.43M | $2.43M | $2.43M | $576000.00 | $267000.00 | $552000.00 | $7000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $6000.00 | $1.21M | $1.05M | $4.09M | $5.21M | $6.62M | $6.71M |
| Free cash flow | $-4.40M | $-20.70M | $-36.11M | $-46.43M | $-52.33M | $-63.15M | $-77.17M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | $-442641.00 | $64.86M | $-46.38M | — | — | — |